Virtus LifeSci Biotech Clinical Trials ETF

  • BBC

31 West 52nd Street,16th Floor
New York , NY, 10019

Rank

Rank Universe
27 23

Summary

The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies in the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests significantly in the component securities of More

Webiste

Directors

Jan 16, 2024
  • Robert S. Tull, Jr.
  • William J. Smalley
  • Myles J. Edwards
  • James A. Simpson

Chief Compliance Officer

  • Timothy Branigan

Price

  • $ 25.26 ( +1.25 )
  • Jun 28, 2024
    Last Close
  • Net Assets
  • $10.1M
    Mar 28, 2024
  • 52-Week High/Low
  • $28.1 - $24.6

  • Expense Ratio
  • -

Performance

YTD

0%

3 Year

-50.2%

5 Year

-10.71%

Best

63.71%

2019

Worst

-48.54%

2008

Documents

NAV

Annual Return

Alpha - BBC and S&P